Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Century Therapeutics (IPSC) Interest Expenses (2022 - 2023)

Century Therapeutics (IPSC) has disclosed Interest Expenses for 2 consecutive years, with $136000.0 as the latest value for Q2 2023.

  • On a quarterly basis, Interest Expenses fell 66.5% to $136000.0 in Q2 2023 year-over-year; TTM through Mar 2024 was $136000.0, a 92.32% decrease, with the full-year FY2023 number at $540000.0, down 62.24% from a year prior.
  • Interest Expenses was $136000.0 for Q2 2023 at Century Therapeutics, down from $348000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $643000.0 in Q4 2022 to a low of $136000.0 in Q2 2023.